In a cohort of patients with early stage (i.e., stage I–II) melanoma, IDO expression in the sentinel lymph node was an independent negative prognostic factor for PFS and OS [152], as well as its expression in primary melanoma [148]. Here, IDO1 is linked to melanoma.